EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A Somatic Mutation in HIF ‐2α Affects Glucose and Lipid Metabolism via CD36 and Ceramide

Feiqiong Gao, Xudong Feng, Qigu Yao, Weiqin Ji, Xinying Zhang, Qiaoling Pan, Bin Zhu, Jiong Yu, Hongcui Cao, Xianfeng Zhang iD

The FASEB Journal · 2026

DOI: 10.1096/fj.202502296rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Feiqiong Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China. Hauptthemen laut MEDLINE: Lipid Metabolism, Basic Helix-Loop-Helix Proteins, Glucose, CD36 Antigens. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Key Research and Development Project of Zhejiang Province, Central Guidance Fund for Local Science and Technology Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia‐inducible factor 2 α (HIF‐2 α ) plays a critical role in metabolic regulation. Previously, our team identified a novel mutation (c.C2473T, p.R825W) within the C‐terminal transactivation domain of HIF‐2 α , which was associated with the pathogenesis of non‐alcoholic fatty liver disease. The present study aimed to investigate the relationship between this mutation and disorders of glucose and lipid metabolism, and to elucidate the underlying mechanisms. A HIF‐2 α mutant C56BL/6 mouse model and THLE‐2 and HEK293 cell lines carrying the same mutation were established. Co‐immunoprecipitation and western blot were used to assess the molecular effects of the mutation. Transcriptome sequencing, quantitative real‐time PCR, and western blotting were performed to identify differentially expressed genes, while lipidomics was applied to evaluate ceramide profiles in mutant and control mice. Herein, we found that HIF‐2 α mutant mice exhibited impaired glucose tolerance and enhanced transactivation activity of the mutant protein. The AMP‐activated protein kinase (AMPK) pathway was significantly upregulated in mutant models. Notably, Cd36 , a gene in this pathway, showed increased expression in both mutant mice and cell lines. Ceramide levels were elevated in the mutant group, and positively correlated with hepatic triglyceride accumulation. Inhibition of ceramide synthesis decreased the expression of genes involved in gluconeogenesis and fatty acid transport and reduced hepatic lipid droplet formation in mutant mice. Collectively, these findings indicate that the HIF‐2 α mutation enhances Cd36 expression by increased transactivation activity, thereby elevating ceramide level and disrupting glucose and lipid homeostasis. This study provides a theoretical basis for precise treatment of metabolic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid MetabolismBasic Helix-Loop-Helix ProteinsGlucoseCD36 AntigensCeramidesMutationAnimalsMiceHumansHEK293 CellsMice, Inbred C57BLMaleLiverEndothelial PAS Domain-Containing Protein 1

Stichwörter der Autor:innen

CD36ceramideglucose and lipid metabolismhypoxia‐inducible factor 2αmutation

Substanzen

Basic Helix-Loop-Helix ProteinsGlucoseCD36 AntigensCeramidesEndothelial PAS Domain-Containing Protein 1Cd36 protein, mouse

Autor:innen und Institutionen

  • Department of Endocrinology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
  • Department of Clinical Laboratory, Ningbo Medical Center Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, Ningbo, China.
  • State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, National Medical Center for Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
  • Zhejiang Key Laboratory for Diagnosis and Treatment of Physic-Chemical and Aging-Related Injuries, Hangzhou, China.
  • National Clinical Research Center for Infectious, Hangzhou, China.

ORCID-Profile: Xianfeng Zhang

Förderung

  • Zhejiang Provincial Natural Science Foundation of China
  • Key Research and Development Project of Zhejiang Province
  • Central Guidance Fund for Local Science and Technology Development
  • the Fundamental Research Funds for the Central Universities
  • High level Personnel Cultivating Project of Zhejiang Province
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Gao, F., Feng, X., Yao, Q., Ji, W., Zhang, X., Pan, Q., Zhu, B., Yu, J., Cao, H., & Zhang, X. (2026). A Somatic Mutation in HIF ‐2α Affects Glucose and Lipid Metabolism via CD36 and Ceramide. The FASEB Journal. https://doi.org/10.1096/fj.202502296rr

Vancouver

Gao F, Feng X, Yao Q, Ji W, Zhang X, Pan Q, et al. A Somatic Mutation in HIF ‐2α Affects Glucose and Lipid Metabolism via CD36 and Ceramide. The FASEB Journal. 2026. doi:10.1096/fj.202502296rr

BibTeX
@article{Gao2026,
  author = {Gao, Feiqiong and Feng, Xudong and Yao, Qigu and Ji, Weiqin and Zhang, Xinying and Pan, Qiaoling and Zhu, Bin and Yu, Jiong and Cao, Hongcui and Zhang, Xianfeng},
  title = {A Somatic Mutation in HIF ‐2α Affects Glucose and Lipid Metabolism via CD36 and Ceramide},
  journal = {The FASEB Journal},
  year = {2026},
  doi = {10.1096/fj.202502296rr}
}
Kostenlos starten →